A month after desi Ozempic's debut, vitamin market expands 10%
·1 min read
·
0 reactions
·
0 comments
·
25 views
MUMBAI: Just a month after the Ozempic-famed weight-loss and diabetes medicine semaglutide entered the market as a generic, there has been a sudden surge in the demand for nutraceuticals, like multivitamin supplements. As patients on GLP-1 receptor agonists, a new class of anti-obesity medicines, face the risk of micronutritional loss, these supplements are being prescribed by clinicians to make up for the deficit.
About this source
Times of India — Top publishes from India and files mainly under world. We currently carry 1,659 of its stories.
Original article
Times of India — Top
Anonymous · no account needed